Creation of a virtual antidotes network between pharmacy departments of catalan hospitals
<p><strong>Objetive:</strong> To design a virtual antidote network between hospitals that could help to locate on-line those hospitals that stocked those antidotes with the highest difficulty in terms of availability, and ensured that the medication was loaned in case of nece...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Grupo Aula Médica
2017-05-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/10507.pdf |
| Summary: | <p><strong>Objetive:</strong> To design a virtual antidote network between hospitals that could help to locate on-line those hospitals
that stocked those antidotes with the highest difficulty in terms of availability, and ensured that the medication was loaned in case of
necessity.</p><p><strong>Methods:</strong> The application was developed by four hospital pharmacists and two clinical toxicologists with
the support of a Healthcare Informatics Consultant Company.</p><p><strong>Results:</strong> The antidotes network in Catalonia, Spain,
was launched in July 2015. It can be accessed through the platform: www.xarxaantidots.org. The application has an open area with overall
information about the project and the option to ask toxicological questions of non-urgent nature. The private area is divided into four sections:
1) Antidotes: data of interest about the 15 antidotes included in the network and their recommended stock depending on the complexity of the
hospital, 2) Antidote stock management: virtual formulary, 3) Loans: location of antidotes through the on-line map application Google Maps,
and virtual loan request, and 4) Documentation: As of June, 2016, 40 public and private hospitals have joined the network, from all four
provinces of Catalonia, which have accessed the private area 2 102 times, requested two loans of silibinin, one of hydroxocobalamin, three of
antiophidic serum and three of botulism antitoxin. Thirteen toxicological consultations have been
received.</p><p><strong>Conclusions:</strong> The implementation of this network improves the communication between centers that
manage poisoned patients, adapts and standardizes the stock of antidotes in hospitals, speeds up loans if necessary, and improves the quality
of care for poisoned patients.</p><p> </p>
|
|---|---|
| ISSN: | 1130-6343 2171-8695 |